:::

詳目顯示

回上一頁
題名:臺灣版糖尿病生活品質測量工具Diabetes-39的發展與驗證
書刊名:臺灣公共衛生雜誌
作者:黃情川黃一展吳明彥陳姿君吳菁珍林文德 引用關係
作者(外文):Hwang, Chyng-chuangHuang, I-chanWu, Ming-yenChen, Tzu-chunWu, Jing-jhenLin, Wender
出版日期:2009
卷期:28:3
頁次:頁218-231
主題關鍵詞:糖尿病生活品質Diabetes-39臺灣版心理計量Diabetes mellitusQuality of lifeD-39 Chinese versionPsychometric property
原始連結:連回原系統網址new window
相關次數:
  • 被引用次數被引用次數:期刊(0) 博士論文(0) 專書(0) 專書論文(0)
  • 排除自我引用排除自我引用:0
  • 共同引用共同引用:42
  • 點閱點閱:102
目標:進行糖尿病生活品質測量工具D-39中文版的翻譯及驗證。方法:橫斷式研究法。對象為署立台南醫院糖尿病門診病患280人。資料收集為病人問卷與病歷摘要。病歷摘要收集臨床變項用以驗證D-39,包括實驗室診斷(醣化血色素、飯前與飯後2小時血糖)與糖尿病併發症(視網膜病變、腎臟病變、神經病變、足部病變、心血管疾病、及腦血管疾病)。心理計量分析包括信度與效度。結果:翻譯結果顯示,中文版D-39在語意上與英文版相似,且能被病人接受。心理計量分析發現,D-39中文版的測量結構與英文版相吻合。D-39與SF-36(效標)同質性面向之相關性較異質性面向強。D-39對於飯後2小時血糖及肌酸酐等指標,及心血管疾病、腦血管疾病、與足部病變等併發症,分別呈現有意義的預知組別效度(效果量>0.2)。D-39對於神經病變、腦血管疾病、視網膜病變、足部病變、心血管疾病、與腎臟病變的綜合鑑別效度達到可接受的標準(C-統計值>0.7)。結論:本研究翻譯並驗證了中文版D-39,其結果將有助於糖尿病人健康結果之評估。
Objectives: The Diabetes-39 (D-39) is a well-validated and widely used diabetes quality of life (QOL) instrument. The purpose of this study was to translate the D-39 into Chinese and test its psychometric properties. Methods: Data were collected from 280 patients treated in diabetes clinics of the Tainan Hospital, Taiwan Department of Health, through QOL survey and medical record review. Information collected from medical records, used to validate the D-39, included laboratory indicators (hemoglobin A1c (HbA1c), fasting plasma glucose, 2-hour postprandial plasma glucose (2-h PPG), creatinine (Cr), and glomerular filtration rate) and diabetes complications (retinopathy, nephropathy, neuropathy, diabetic foot complications, cardiovascular complications, and cerebrovascular complications). We conducted forward/back translations and a focus group session to develop the Chinese version of the instrument. For psychometric evaluation, we analyzed construct validity, convergent/discriminant validity (using the SF-36 as the standard), known-group validity, and overall discriminant validity of the D-39. Results: The D-39 Chinese version demonstrated equivalent semantics to the original D-39. Pearson's correlations were weak with subscales measuring heterogeneous constructs between the D-39 and SF-36, but high among subscales measuring homogenous constructs, suggesting good convergent/discriminant validity. The D-39 discriminated better for 2-h PPG, Cr, cardiovascular, cerebrovascular, and diabetic foot complications (effect size >0.2), suggesting good knowngroup validity. C-indexes suggested greater discrimination (>0.7) by the D-39 compared to the SF-36 across all complications, indicating good overall discriminate validity. Conclusions: Our successfully translated D-39 demonstrated good psychometric properties. The D-39 Chinese version is an acceptable instrument for assessing treatment effectiveness and monitoring patient outcomes in Taiwan.
期刊論文
1.Hahl, J.、Hamalainen, H.、Sintonen, H.、Simell, T.、Arinen, S.、Simell, O.(2002)。Health-related quality of life in type 1 diabetes without or with symptoms of long-term complications。Quality of Life Research,11,427-436。  new window
2.Saito, I.、Inami, F.、Ikebe, T.、Moriwaki, C.、Tsubakimoto, A.、Yonemasu, K.(2006)。Impact of diabetes on health-related quality of life in a population study in Japan。Diabetes Research & Clinical Practice,73,51-57。  new window
3.Chobanian, A. V.、Bakris, G. L.、Black, H. R.、Cushman, W. C.、Green, L. A.、Izzo, J. J.、Oparil, S.(2003)。The Seventh Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure。JAMA,289(19),2560-2572。  new window
4.Hanley, J. A.、McNeil, B. J.(1982)。The meaning and use of the area under a receiver operating characteristic (ROC) curve。Radiology,143(1),29-36。  new window
5.American Diabetes Association.(2007)。Standards of Medical Care in Diabetes-2007。Diabetes Care,30(Supple 1),S4-S41。  new window
6.National Kidney Foundation(2002)。K/DOQI clinical practice guidelines for chronic kidney disease: Evaluation, classification, and stratification。American Journal of Kidney Diseases,39(2),1-266。  new window
7.Jacobson, A. M.、de Groot, M.、Samson, J. A.(1994)。The Evaluation of Two Measures of Quality of Life in Patients with Type I and Type II Diabetes。Diabetes Care,17(4),267-274。  new window
8.Gill, T. M.、Feinstein, A. R.(1994)。A Critical Appraisal of the Quality of Quality-of-life Measurements。JAMA: The Journal of the American Medical Association,272(8),619-626。  new window
9.曾旭民、盧瑞芬、蔡益堅(20031200)。國人生活品質評量(Ⅱ):SF-36臺灣版的常模與效度檢測。臺灣公共衛生雜誌,22(6),512-518。new window  延伸查詢new window
10.Revicki DA, Osoba D, Fairclough D, etal.(2000)。Recommendations on health-related quality of life to support labeling and promotional claims in the United States。Qual Life Res,9,887-900。  new window
11.de Vet HC, Ader HJ, Terwee CB, Pouwer F.(2005)。Are factor analytical techniques used appropriately in the validation of health status questionnaires? A systematic review on the quality of factor analysis of the SF-36。Qual Life Res,14,1203-24。  new window
12.Glasgow RE, Ruggiero L, Eakin EG, Dryfoos J, Chobanian L.(1997)。Quality of life and associated characteristics in a large national sample of adults with diabetes。Diabetes Care,20,562-7。  new window
13.Hanley JA, McNeil BJ.(1983)。A method of comparing the areas under receiver operating characteristic curves derived from the same cases。Radiology,148,839-43。  new window
14.Arauz-Pacheco C, Parrott MA, Raskin P, American Diabetes Association.(2003)。Treatment of hypertension in adults with diabetes。Diabetes Care,26(suppl 1),S80-582。  new window
15.Testa MA, Simonson DC.(1998)。Health economic benefits and quality of life during improved glycemic control in patients with type 2 diabetes mellitus: a randomized, controlled, double-blind trial。JAMA,280,1490-6。  new window
16.Testa MA, Simonson DC, Turner RR.(1998)。Valuing quality of life and improvements in glycemic control in people with type 2 diabetes。Diabetes Care,21(Suppl 3),C44-52。  new window
17.Wikblad K, Leksell J, Wibell L.(1996)。Health-related quality of life in relation to metabolic control and late complications in patients with insulin dependent diabetes mellitus。Qual Life Res,5,123-30。  new window
18.UK Prospective Diabetes Study Group.(1999)。Quality of life in type 2 diabetic patients is affected by complications but not by intensive policies to improve blood glucose or blood pressure control (UKPDS 37)。Diabetes Care,22,1125-36。  new window
19.Anderson RM, Fitzgerald JT, Wisdom K, Davis WK, Hiss RG.(1997)。A comparison of global versus diseasespecific quality-of-life measures in patients with0 NIDDM。Diabetes Care,20,299-305。  new window
20.Wei JN, Chuang LM, Lin RS, Chao CL, Sung FC.(2000)。Prevalence and hospitalization rates of diabetes mellitus in Taiwan。J Public Health,21,173-80。  new window
21.World Health Organization Quality of Life Group.(1982)。The World Health Organization Quality of Life assessment (WHOQOL): position paper from the World Health Organization, 1995b。Soc Sci Med,41,1403-9。  new window
22.Berzon R, Hays RD, Shumaker SA.(1993)。International use, application and performance of health-related quality of life instruments。Qual Life Res,2,367-8。  new window
23.Naughton MJ, Shumaker SA.(2003)。The case for domains of function in quality of life assessment。Qual Life Res,12(Suppl 1),73-80。  new window
24.Garratt AM, Schmidt L, Fitzpatrick R.(2002)。Patient assessed health outcome measures for diabetes: a structured review。Diabet Med,19,1-11。  new window
25.Watkins K, Connell CM.(2004)。Measurement of healthrelated QOL in diabetes mellitus。Pharmacoeconomics,22,1109-26。  new window
26.Huang MC, Hung CH.(2007)。Quality of life and its predictors for middle-aged and elderly patients with type 2 diabetes mellitus。J Nurs Res,15,193-201。  new window
27.Li TC, Lee YD, Lin CC, Amidon RL.(2004)。Quality of life of primary caregivers of elderly with cerebrovascular disease or diabetes hospitalized for acute care: assessment of well-being and functioning using the SF-36 health questionnaire。Qual Life Res,13,1081-8。  new window
28.Li TC, Lin CC, Liu CS, Li CI, Lee YD.(2006)。Validation of the Chinese version of the diabetes impact measurement scales amongst people suffering from diabetes。Qual Life Res,15,1613-9。  new window
29.Boyer JG, Earp JA.(1997)。The development of an instrument for assessing the quality of life of people with diabetes. Diabetes-39。Med Care,35,440-53。  new window
30.Wild D, Grove A, Martin M, et al.(2005)。Principles of Good Practice for the Translation and Cultural Adaptation Process for Patient-Reported Outcomes (PRO) Measures: report of the ISPOR Task Force for Translation and Cultural Adaptation。Value Health,8,94-104。  new window
31.Goddijn P, Bilo H, Meadows K, Groenier K, Feskens E, Meyboom-de Jong B.(1996)。The validity and reliability of the Diabetes Health Profile (DHP) in NIDDM patients referred for insulin therapy。Qual Life Res,5,433-42。  new window
32.Maddigan SL, Feeny DH, Johnson JA, DOVE Investigators.(2004)。Construct validity of the RAND-12 and Health Utilities Index Mark 2 and 3 in type 2 diabetes。Qual Life Res,13,435-48。  new window
33.Bonora E, Muggeo M.(2001)。Postprandial blood glucose as a risk factor for cardiovascular disease in Type II diabetes: the epidemiological evidence。Diabetologia,44,2107-14。  new window
34.Ceriello A.(2005)。Postprandial hyperglycemia and diabetes complications: is it time to treat?。Diabetes,54,1-7。  new window
35.Gerich, J. E.(2003)。Clinical significance, pathogenesis, and management of postprandial hyperglycemia。Archives of Internal Medicine,163,1306-1316。  new window
36.The Diabetes Control and Complications Trial.(1995)。The relationship of glycemic exposure (HbA1c) to the risk of development and progression of retinopathy in the diabetes control and complications trial。Diabetes,44,968-83。  new window
37.Cavalit F, Petrelli A, Traversa M, et al.(2006)。Postprandial blood glucose is a stronger predictor of cardiovascular events than fast blood glucose in type 2 diabetes mellitus, particularly in women: lesions from the San Luigi Gonzaga Diabetes Study。J Clin Endocrinol Metab,91,813-9。  new window
38.Lloyd CE, Mattews KA, Wing RR, Orchard TJ.(1992)。Psychosocial factors and complications of IDDM. The Pittsburgh Epidemiology of Diabetes Complications Study. VIII。Diabetes Care,15,166-72。  new window
39.Rijken M, van Kerkhof M, Dekker J, Schellevis FG.(2005)。Comorbidity of chronic diseases: effects of disease pairs on physical and mental functioning。Qual Life Res,14,45-55。  new window
40.Johnson JA, Maddigan SL.(2004)。Performance of the RAND-12 and SF-12 summary scores in type 2 diabetes。Qual Life Res,13,449-56。  new window
41.Crosby RD, Kolotkin RL, Williams GR.(2003)。Defining clinically meaningful change in health-related quality of life。J Clin Epidemiol,56,395-407。  new window
圖書
1.Nunnally, Jum C.、Bernstein, Ira H.(1994)。Psychological theory。MacGraw-Hill。  new window
2.Kasper DL, Braunwald E, Hauser S, et al.(2004)。Harrison’s Principles of Internal Medicine。New York。  new window
 
 
 
 
第一頁 上一頁 下一頁 最後一頁 top
:::
無相關書籍
 
無相關著作
 
無相關點閱
 
QR Code
QRCODE